Abstract
During the past two years, porcine-derived, xenogeneic extracellular matrix (ECM) has been used as a scaffold for several tissue engineering applications in more than 100,000 human patients. ECM contain numerous growth factors that are arranged in a unique ultrastructure that supports constructive tissue remodeling. A review is given of the clinical experience, including the immunologic response of the patients to this xenogenetic scaffold.
| Original language | English |
|---|---|
| Pages (from-to) | 752 |
| Number of pages | 1 |
| Journal | Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings |
| Volume | 1 |
| State | Published - 2002 |
| Externally published | Yes |
| Event | Proceedings of the 2002 IEEE Engineering in Medicine and Biology 24th Annual Conference and the 2002 Fall Meeting of the Biomedical Engineering Society (BMES / EMBS) - Houston, TX, United States Duration: 23 Oct 2002 → 26 Oct 2002 |